- Medical Cannabis Home
- For Patients
- For Caregivers
- For Health Care Practitioners
- For Public Safety
- Laws and Rules
- Print Materials and Forms
- Registry Login/Create Account
- Petitions Process
- Data and Reports
- About the Medical Cannabis Program
Medical Cannabis Clinical Trials
The US National Institutes of Health maintains a website that reports publicly and privately supported clinical studies of human participants conducted around the world: ClinicalTrials.gov.
The website has a search mechanism that allows persons to search for trials of interest to them, for example “Crohn’s Disease” and “cannabis”. The search produces a list of studies that meet the search criteria: completed studies, studies currently enrolling patients, and studies still in the planning stage.
Per Minnesota 2014 Statute 152.24, the Office of Medical Cannabis (OMC) will list in a section of the website clinical trials involving qualifying medical conditions in the Minnesota Medical Cannabis Program that have a study site in Minnesota. Below are the studies OMC is now aware of that meet this criteria:
- The Mayo Clinic is participating in clinical trials of cannabidiol for medication-resistant seizures in very specific patient populations. A subset of children and young adults with Dravet’s Syndrome or Lennox-Gastaut Syndrome will be eligible. For more information, contact firstname.lastname@example.org.